Credit Agricole
VIR icon

Credit Agricole’s Vir Biotechnology VIR Stock Holding History

Credit Agricole’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,300
Closed -$156K – 739
2021
Q2 		$156K Hold
3,300
– – ﹤0.01% 387
2021
Q1 		$169K Buy
+3,300
New +$178K ﹤0.01% 350

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Credit Agricole's VIR Position: Q3 2021 in Review

Credit Agricole sold out of Vir Biotechnology (VIR) in Q3 2021, closing a stake of 3,300 shares — an estimated $156K sold.

Credit Agricole first reported a position in VIR in Q1 2021 and held it in 2 quarters. The position peaked at $169K in Q1 2021. 175 funds tracked by Wall St. Rank hold VIR as of Q3 2021.

  • Credit Agricole reported no remaining Vir Biotechnology position as of Q3 2021 after selling out during the quarter.
  • Credit Agricole sold 3,300 Vir Biotechnology shares in Q3 2021, an estimated $156K.
  • Credit Agricole first reported a position in Vir Biotechnology in Q1 2021 and held it in 2 quarters.
  • Credit Agricole's Vir Biotechnology position peaked at $169K in Q1 2021.
  • 175 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2021.

Based on Credit Agricole's 13F filing for Q3 2021, filed 15 Nov 2021.